Head-to-Head

Johnson & Johnson vs. Rigel Pharmaceuticals Inc. (New)

JNJ

Johnson & Johnson

$262.37 +0.78%

VS RIGL

Rigel Pharmaceuticals Inc. (New)

$42.45 -0.31%

Rigel Pharmaceuticals Inc. (New) (RIGL) comes out ahead, leading on 5 of 9 compared factors.

Size & Scale

JNJRIGL
Market Cap $627.42 billion $795.39 million
Revenue (TTM) $97.93 billion $276.79 million
Net Income (TTM) $21.04 billion $321.91 million

JNJ leads on 3 of 3 size & scale factors.

Valuation

JNJRIGL
P/E Ratio 30.44 2.51
Price / Book 7.38 1.87
Price / Sales 6.41 2.87

RIGL leads on 3 of 3 valuation factors.

Profitability

JNJRIGL
Net Margin 21.48% 116.30%
Return on Equity 24.76% 75.67%

RIGL leads on 2 of 2 profitability factors.

Dividend

JNJRIGL
Dividend Yield 2.04% —
Payout Ratio 62.18 —

JNJ and RIGL split the dividend factors evenly.

Risk & Sentiment

JNJRIGL
Short Interest 0.67% 42.81%

JNJ leads on 1 of 1 risk & sentiment factors.

Dig deeper: JNJ overview, JNJ financials, RIGL overview, RIGL financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.